{"first_name":"Ted","last_name":"Hibben","permalink":"ted-hibben-2","crunchbase_url":"http://www.crunchbase.com/person/ted-hibben-2","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Sat Nov 10 14:19:27 UTC 2012","updated_at":"Sat Nov 10 14:22:34 UTC 2012","overview":"<p>Ted Hibben joined Ensemble Therapeutics in September 2010 as Senior Vice President, Corporate Development.  He brings to Ensemble nearly 20 years of biotech experience in business and corporate development and strategy, venture fundraising, M&amp;A and on leadership teams associated with a variety of early-to-mid development stage therapeutic technology platforms addressing inflammation, cancer, autoimmune and infectious diseases.  Ted came to Ensemble from Cequent Pharmaceuticals, a company developing therapeutics based on RNAi, where he was Chief Business Officer and played a key role in effecting Cequent’s $46 million merger with MDRNA, Inc. (now Marina Biotech).  Prior to Cequent, he was Vice President, Business Development and Alliance Management at Coley Pharmaceutical Group where he sourced and/or managed nine development collaborations and led the process to sell Coley to Pfizer for $233 million in 2008.  Earlier, Ted was integral to advancing Centagenetix’s merger with Elixir, Ontogeny’s merger with Creative BioMolecules to form Curis, and Marathon Biopharmaceutical’s acquisition by Ligand.</p>","image":{"available_sizes":[[[96,122],"assets/images/resized/0021/9828/219828v1-max-150x150.jpg"],[[96,122],"assets/images/resized/0021/9828/219828v1-max-250x250.jpg"],[[96,122],"assets/images/resized/0021/9828/219828v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"M.B.A. ","subject":"","institution":"Harvard University","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Senior Vice President, Corporate Development ","firm":{"name":"Ensemble Therapeutics","permalink":"ensemble-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[150,36],"assets/images/resized/0021/8602/218602v1-max-150x150.jpg"],[[250,61],"assets/images/resized/0021/8602/218602v1-max-250x250.jpg"],[[302,74],"assets/images/resized/0021/8602/218602v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}